# A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps

> **NCT06036927** · PHASE2 · COMPLETED · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 80 (actual)

## Conditions studied

- Chronic Sinusitis
- Nasal Polyps

## Interventions

- **DRUG:** TQC2731 injection
- **DRUG:** TQC2731 matching placebo

## Key facts

- **NCT ID:** NCT06036927
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-08
- **Primary completion:** 2025-02-05
- **Final completion:** 2025-03-27
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036927, "A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06036927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*